The brokerage has a sell call on Dr Lal with a target price of ₹1,740, implying a potential downside of over 30 percent. Meanwhile, it has a reduce call on Metropolis with a target price of ₹1,350, indicating an over 7 percent downside.
Dr Lal Pathlabs Share/Stock Price Today: Check Dr Lal Pathlabs Live NSE/BSE, Historic price charts. Read Dr Lal Pathlabs news, profit & loss account, buy-sell, announcements, financial report, company information, annual report, balance sheet, results at Mint